ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Global Cord Blood's annualizedNet Income for the quarter that ended in Mar. 2022 was $66.0 Mil.
Global Cord Blood's average Total Assets over the quarter that ended in Mar. 2022 was $1,331.8 Mil. Therefore, Global Cord Blood's annualized ROA % for the quarter that ended in Mar. 2022 was 4.96%.
The historical rank and industry rank for Global Cord Blood's ROA % or its related term are showing as below:
CORBF's ROA % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -1.87 * Ranked among companies with meaningful ROA % only.
Global Cord Blood (OTCPK:CORBF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2022) net income data. The Revenue data used here is four times the quarterly (Mar. 2022) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Global Cord Blood ROA % Related Terms
Global Cord Blood ROA % Historical Data
* Premium members only.
The historical data trend for Global Cord Blood's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Global Cord Blood's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Cord Blood ROA % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's ROA % distribution charts can be found below:
* The bar in red indicates where Global Cord Blood's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2022) net income data.
ROA % is displayed in the 30-year financial page.
Global Cord Blood (CORBF) has a ROA % of 4.96% as of Mar. 2022. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Global Cord Blood and its competitors.
Is Global Cord Blood's ROA % too high?
Global Cord Blood's current ROA % is 4.96%. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's ROA % compare to PRE and LMDX?
Global Cord Blood's ROA % of 4.96% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Diagnostics & Research company?
A good ROA % depends on the Medical Diagnostics & Research industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Global Cord Blood and its competitors. Global Cord Blood's current ROA % is 4.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current ROA % of 4.96%. The current ROA % is 4.96%. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current ROA % is 4.96% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score
Get the complete analysis for CORBF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CORBF has been successfully added to your 
